Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.21.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock option-based compensation for the three months ended March 31, 2021 and 2020:

 

    For the three months ended March 31,  
    2021     2020  
Research and development   $ 609,000     $ 744,000  
General and administrative     474,000       512,000  
Stock option-based compensation expense  included in operating expense     1,083,000       1,256,000  
                 
Total stock option-based compensation expense     1,083,000       1,256,000  
Tax benefit     -       -  
Stock option-based compensation expense, net of tax   $ 1,083,000     $ 1,256,000  
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS TO ESTIMATE THE FAIR VALUE OF THE OPTIONS GRANTED

We used the following weighted-average assumptions to estimate the fair value of the options granted for the periods indicated:

 

    For the three months ended March 31,  
    2021     2020  
Expected volatility     99%       111%  
Expected term     6.08 years       6.25 years  
Risk-free interest rate     1.00%       0.43%  
Expected dividend yield     0%       0%  

SCHEDULE OF OPTIONS ACTIVITY

The following table summarizes the options granted for the periods indicated:

 

    For the three months ended March 31,  
    2021     2020  
Options granted     2,149,500       1,175,927  
Weighted-average:                
Exercise price   $ 2.29     $ 1.45  
Grant date fair value   $ 1.80     $ 1.21  

Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF STOCK BASED COMPENSATION

Restricted Common Stock: The following table summarizes restricted common stock compensation expense for the three months ended March 31, 2021 and 2020:

 

    For the three months ended March 31,  
    2021     2020  
Research and development   $ 546,000     $ 325,000  
General and administrative     321,000       139,000  
Restricted stock-based compensation expense included in operating expense     867,000       464,000  
                 
Total restricted stock-based compensation expense     867,000       464,000  
Tax benefit     -       -  
Restricted stock-based compensation expense, net of tax   $ 867,000     $ 464,000